(Q37315670)

19 August 2017

1 reference

title

NK cells and Treg cells: a fascinating dance cheek to cheek (English)

1 reference

19 August 2017

Jacques Zimmer

1

1 reference

19 August 2017

Emmanuel Andrès

series ordinal

2

1 reference

19 August 2017

François Hentges

series ordinal

3

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

European Journal of Immunology

19 August 2017

published in

1 reference

19 August 2017

volume

38

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

2942-2945

1 reference

CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

T regulatory cells control numbers of NK cells and CD8alpha+ immature dendritic cells in the lymph node paracortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

How many mechanisms do regulatory T cells need?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Regulatory T cells: friend or foe in immunity to infection?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Cutting edge: direct suppression of B cells by CD4+ CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Modulation of monocyte/macrophage function by human CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Functions of natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Control of NK cell functions by CD4+CD25+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Regulatory T cells inhibit Fas ligand-induced innate and adaptive tumour immunity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Human T regulatory cells can use the perforin pathway to cause autologous target cell death

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Donor double-negative Treg promote allogeneic mixed chimerism and tolerance

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Cytokine expression by murine DX5+ cells in response to IL-12, IL-18, or the combination of IL-12 and IL-18

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Interleukin-2, interleukin-15, and their roles in human natural killer cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

NK cells lyse T regulatory cells that expand in response to an intracellular pathogen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Surface cathepsin B protects cytotoxic lymphocytes from self-destruction after degranulation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Clinical application of regulatory T cells for treatment of type 1 diabetes and transplantation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Regulatory T cells in ovarian cancer: biology and therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Transient T cell depletion causes regression of melanoma metastases

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838813

7 January 2021

Identifiers

DOI

10.1002/EJI.200838813

1 reference

19 August 2017

1 reference